Your browser doesn't support javascript.
loading
[Acute myeloid leukemia with t (8;21) translocation diagnosed at 21 weeks of gestation resulting in full-term delivery without chemotherapy].
Norihama, Yuka; Nomura, Moe; Oda, Yuki; Kasuya, Yuki; Takei, Tomomi; Sato, Kota; Ogura, Mizuki; Kikuchi, Taku; Abe, Yu; Ishida, Tadao; Kasai, Yasuyo; Tsukada, Nobuhiro.
  • Norihama Y; Department of Obstetrics and Gynecology, Japanese Red Cross Medical Center.
  • Nomura M; Department of Hematology, Japanese Red Cross Medical Center.
  • Oda Y; Department of Hematology, Japanese Red Cross Medical Center.
  • Kasuya Y; Department of Hematology, Japanese Red Cross Medical Center.
  • Takei T; Department of Hematology, Japanese Red Cross Medical Center.
  • Sato K; Department of Hematology, Japanese Red Cross Medical Center.
  • Ogura M; Department of Hematology, Japanese Red Cross Medical Center.
  • Kikuchi T; Department of Hematology, Japanese Red Cross Medical Center.
  • Abe Y; Department of Hematology, Japanese Red Cross Medical Center.
  • Ishida T; Department of Hematology, Japanese Red Cross Medical Center.
  • Kasai Y; Department of Obstetrics and Gynecology, Japanese Red Cross Medical Center.
  • Tsukada N; Department of Hematology, Japanese Red Cross Medical Center.
Rinsho Ketsueki ; 64(8): 731-734, 2023.
Article en Ja | MEDLINE | ID: mdl-37673623
ABSTRACT
A 28-year-old female was diagnosed with acute myeloid leukemia (AML) due to t (8;21) (q22;q22.1); RUNX1-RUNX1T1 at 21 weeks of gestation. Because no adverse prognostic genetic mutations were discovered, we decided to continue the pregnancy without chemotherapy for as long as possible. After careful monitoring with blood tests every two weeks, the disease did not progress until full-term, and a cesarean section was performed at 39 weeks of gestation. About two months after delivery, blasts in the peripheral blood increased to 46.5%, and myeloblasts in the bone marrow increased to 21.2%. The patient received idarubicin and cytarabine induction therapy, followed by three cycles of high-dose cytarabine consolidation therapy, and complete remission was maintained. Here we report a rare case who could avoid chemotherapy until full-term labor without progression of AML.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Cesárea Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Pregnancy Idioma: Ja Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Cesárea Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Pregnancy Idioma: Ja Año: 2023 Tipo del documento: Article